News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sanofi-Aventis (France) (SASY.PA) And Merck KGaA (MKGAF.PK) Sign Cancer Drug Deal



12/17/2010 7:48:48 AM

Bloomberg -- Sanofi-Aventis SA and Merck KGaA agreed to jointly study experimental cancer treatments. Sanofi and Darmstadt, Germany-based Merck will conduct early stage human trials of Merck’s MSC1936369B and Sanofi’s SAR245409 and SAR245408 experimental drugs, Paris-based Sanofi said in an e-mailed statement today. Financial details weren’t disclosed.

Read at Vancouver Sun
Read at Nasdaq
Read at Trading Markets.com
Read at Reuters
Read at Bloomberg


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES